Company lists
The Boston edition · 2026

Healthcarecompanies in Boston

Biopharma, care services, pharmaceuticals, care delivery, startups and more: the companies building healthcare in Boston, Massachusetts, with their founders, funding, team size and business models.

369 company profiles51 with recorded fundingNovember 2026 edition
Boston · Photo: Wikimedia Commons (CC BY-SA 4.0)

Recent healthcare business events in Boston

Funding, M&A, contract wins and launches involving 460 healthcare companies in Boston, last 24 months: 52 M&A deals · 21 Contracts · 17 funding rounds. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Apr 2026.

M&AAcquisition · Announced

Orlando health acquires Steward health care

Orlando Health’s recent acquisitions, including its purchase of Baptist Health and buys of three facilities owned by Steward Health Care in Florida, are expected to support “continued…

Health System
M&AAcquisition · Announced

Eli lilly acquires Centessa pharmaceuticals

Centessa Pharmaceuticals PLC (NASDAQ:CNTA) agreed to be acquired by Eli Lilly and Co (NYSE:LLY) for a total value of around $8 billion.

Pharmaceuticals
Funding

Dane street

Quad-C Management, a middle market private equity firm, announced an investment in Dane Street

Healthcare / Insurance Services
M&AAcquisition · Announced

Eli lilly acquires Centessa pharmaceuticals

Eli Lilly and Co. has agreed to acquire Centessa Pharmaceuticals for $38.00 per share in cash plus a contingent value right (CVR) worth up to $9.00 per share, implying a total potential…

Biotechnology
M&AAcquisition · Completed

Bgb group acquires Hayden consulting group

Clearsight Advises Hayden Consulting Group in its Acquisition by BGB Group

Healthcare and Life Sciences Consulting
M&AAcquisition · Announced

Perspective group acquires Na

Perspective Group has also acquired 3 firms this week.

M&AAcquisition

Otsuka acquires Jnana therapeutics

Otsuka, the largest Japanese pharma by revenue, has gone fishing around the world for assets, including Massachusetts-based autoimmune and rare disease company Jnana Therapeutics for…

ContractSupply

Sapphiros · client: Roche

Sapphiros today announced a strategic supply and manufacturing option agreement with Roche that will grant exclusive rights to lateral flow technology manufacturing capacity to at least…

Diagnostics
FundingSeries A

Familywell health

Image: FamilyWell Health has closed an $8 million Series A funding round led by New Markets Venture Partners, with participation from .406 Ventures, GreyMatter Capital, The Alix…

Investors New markets venture partners, .406 Ventures, Greymatter capital, The Alix Foundation
Mental Health
FundingSeed

Aliada therapeutics

Aliada Therapeutics, formed in 2021 with seed funding from RA Capital Management and the venture arm of Johnson & Johnson.

Investors Ra capital management, Johnson & Johnson venture arm
Biotechnology
ContractGovernment

Vertex pharmaceuticals · client: Italian Medicines Agency

Vertex Pharmaceuticals reached a deal with the Italian Medicines Agency to cover its gene editing treatment Casgevy for eligible patients with transfusion-dependent beta thalassemia or…

Pharmaceuticals
FundingSeries B

Mercy bioanalytics

Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the closing of a $59 million series B financing.

Investors Novalis, Sozo ventures, Perceptive Xontogeny Venture Fund, American Cancer Society BrightEdge
Cancer Diagnostics
ContractTechnology

Superluminal medicines · client: Eli lilly

Eli Lilly (LLY) has signed a $1.3 billion deal with privately held biotechnology firm Superluminal Medicines that will see the two companies employ artificial intelligence (AI) for…

M&AAcquisition · Completed

Supernus pharmaceuticals acquires Sage therapeutics

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) ("Supernus") today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (NASDAQ:SAGE)…

Biopharmaceutical
ContractTechnology

Aiolos bio · client: Gsk

In 2024 GSK paid $1 billion to acquire US biotechnology firm Aiolos Bio to obtain a potential asthma treatment that Aiolos had licensed from Hengrui Pharma.

M&AAcquisition · Announced

Supernus pharmaceuticals acquires Sage therapeutics

Under the terms of the agreement, Sage will be acquired by Supernus Pharmaceuticals, Inc. (Nasdaq - SUPN). Supernus will commence a tender offer to acquire all of the outstanding shares…

Pharmaceuticals
M&AAcquisition · Completed

Sevita acquires Shorehaven

Shorehaven: Acquired by Sevita (https://sevitahealth.com), a Minnesota home- and community-based healthcare company, this Maryland intellectual and developmental disability company was…

Intellectual and Developmental Disability
FundingSeries B

Imbria pharmaceuticals

Imbria Pharmaceuticals, Inc., a Boston, MA-based clinical-stage biotechnology company developing novel therapies for cardiometabolic diseases with high unmet need, closed a $57.5m Series…

Investors Deep track capital, AN Ventures, Catalio capital management, Cytokinetics
Biotechnology
FundingGrant

Centering healthcare institute

Centering Healthcare Institute (CHI) today announces a $3 million grant from Elevance Health Foundation.

Investors Elevance health foundation
Healthcare
M&AAcquisition

Bayer acquires Bluerock therapeutics

In August 2019, the firm inked a deal to acquire cell therapy developer BlueRock Therapeutics

Pharmaceuticals
ContractService

Quorum health · client: Steward health care

Quorum Health has finalized an agreement with Steward Health Care to assume ownership of the organization’s remaining IT and revenue cycle Transition Service Agreements (TSAs).

Healthcare
FundingSeries Seed

Surgicure technologies

Surgicure Technologies, a female-owned and operated company dedicated to advancing airway management and patient safety, today announced the closing of a $1.785M Seed funding round led…

Investors Launchpad Venture Group, Gurtin Ventures, BakerBridge Capital, TiE Angels
Medical Device
M&AAcquisition · Announced

Jsi acquires Logicomusa

JSI has acquired LogicomUSA, a provider of voice, network, and contact centre services for broadband providers and electric cooperatives.

FundingInitial Public Offering

Vertex pharmaceuticals

Vertex had sold an initial public offering of 3 million shares of stock at $9 per share.

Biotechnology
FundingSeries D

Surface logix

Surface Logix raised an additional $20M tranche in a Series D round, bringing the total raised to $52M; it was started in October 2005; Venrock Associates, ARCH Venture Partners, CW…

Investors Venrock Associates, Arch venture partners, Cw group, HBM BioVentures
FundingConvertible Notes

Genzyme

Genzyme Corp. is raising $250 million through a private placement of 5.25 percent convertible notes due in 2005 to boost its drug development pipeline, particularly in the area of…

Biotechnology
FundingSeries A

Bluerock therapeutics

Last month, Versant partnered with Bayer AG, of Leverkusen, Germany, to launch the regenerative medicine company Bluerock Therapeutics, with a series A investment of $225 million.

Regenerative Medicine
FundingSeries A

Ziopharm oncology

Ziopharm raised a total of $23 million - $5 million in seed financing followed by an $18 million Series A round last June - before going public via a reverse merger in September.

Biotechnology
FundingSeries A financing

Bionaut pharmaceuticals

Bionaut raised $6.8M in a Series A financing with investors Collinson, Howe & Lennox and HealthCap Venture Capital

Investors Collinson, Howe & Lennox, HealthCap Venture Capital

Healthcare companies in Boston, by funding and team

Few healthcare companies in Boston, Massachusetts publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 369 active companies.

Showing 25 of 50

Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment

Biopharma outsourcing
US$300.00mSeries C · Feb 2022
54-22% vs previous recordLinkedIn · Oct 2026
Physical commerce
7 yr2019
0none in 3 months · last posted Jan 2025

Company developing a drug discovery platform for targeting the solute carrier (SLC) family of transporters

Diversified pharmaceuticals
US$207.00mSeries C · Nov 2022
92-82% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months · last posted Oct 2025

Therapeutics based on recombinant engineered lipocalin mimics

Diversified pharmaceuticals
US$158.69mSeries C · Dec 2014
14+2% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
25 yr2001
0none in 3 months

Generative biological and chemical company focused on drug discovery

Biopharma outsourcing
US$158.00mSeries A · Aug 2025
57LinkedIn · Jul 2026
E-commerce - product / Physical commerce
4 yr2022
0none in 3 months · last posted Jun 2026

Provider of therapeutics solution by translation the cellular metabolism

Diversified pharmaceuticals
US$156.95mSeries B · Nov 2025
16-33% 12 mo to Dec 2021LinkedIn · Jul 2026
Fee-for-service
12 yr2014
0none in 3 months

Manufacturer of diagnostic test devices

Traditional diagnostics
US$127.28mSeries B · Sep 2025
62+157% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Jun 2026

Developer of tissue-targeted therapeutics using in vivo screening and AI design

Medical research labs
US$78.19mSeries A · Nov 2024
68+83% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Jun 2026

Provider of medical research labs

Medical research labs
US$61.59mSeries B · Jul 2024
81+10% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months · last posted May 2026

Provider of neuropsychiatric treatment services

Rehabilitation and long-term care
US$60.00mSeries A · Nov 2022
5+0% vs previous recordrecorded
E-commerce - product / Physical commerce
5 yr2021
0none in 3 months

Developer of RNA-targeted therapeutics for multiple areas

Diversified pharmaceuticals
US$56.10mSeries A · Mar 2022
9-26% vs previous recordLinkedIn · Jul 2026
Subscription
6 yr2020
—No postings tracked

Provider of anxiety management & therapy services

Rehabilitation and long-term care
US$56.00mSeries B · Mar 2024
315+60% vs previous recordLinkedIn · Jul 2026
Fee-for-service
5 yr2021
0none in 3 months · last posted Nov 2025

R&D company focused on manufacturing drugs for multiple therapeutic areas

Diversified pharmaceuticals
US$44.50mSeries B · Jan 2025
15+567% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce / Subscription
7 yr2019
0none in 3 months

Reviews beauty products, ingredients, and promotes informed skincare, hair, and body choices

Diversified pharmaceuticals
US$40.00mSeries B · Nov 2017
25+39% 12 mo to Dec 2022recorded Dec 2022
Physical commerce
10 yr2016
0none in 3 months

Vitro diagnostic company

Diversified diagnostics
US$34.61mSeries B · Jul 2024
17+17% vs previous recordLinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months

Provider of peptide drug discovery and development services for global pharmaceutical industries

Biopharma outsourcing
US$34.22mSeries A · May 2021
8+0% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Jun 2026

Provider of fitness services

Fitness and wellness centers
US$31.62mSeries B · Sep 2025
43LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months

Health organization aims to fights social injustice by bringing the benefits of modern medical science

Healthcare foundations
US$25.00mSeries B · Oct 2022
1,619+30% 12 mo to Dec 2021LinkedIn · Oct 2026
Fee-for-service
39 yr1987
0none in 3 months

CRO focused on providing of drug discovery, pharmacology, and bioanalytical services

Biopharma outsourcing
US$20.25mSeries A · Jul 2024
84LinkedIn · Jul 2026
Subscription
5 yr2021
0none in 3 months

Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers

Services for healthcare providers
US$19.00mSeries A · Mar 2026
—Not available
Commission on transaction / Subscription
0 yr2026
—No postings tracked

Provider of automated bioanalysis platform for accelerated clinical drug development

Biopharma outsourcing
US$17.50mSeries A · Jun 2025
38LinkedIn · Jul 2026
Subscription
2 yr2024
0none in 3 months

Contract research organization that offers a complete suite of CRO services for decentralized clinical trials

Biopharma outsourcing
US$16.43mSeries A · Nov 2022
26recorded
Subscription
7 yr2019
—No postings tracked

Provider of integrated perinatal mental health services for OB clinics. These services are delivered through a collaborative care model, integrating behavioral health support into existing obstetric practices. The model includes access to psychiatrists for medication management and billing support to facilitate insurance reimbursement. Services are offered both in-person and virtually, providing convenient access to mental health support for pregnant and postpartum patients. A certification program for perinatal behavioral health coaches is also offered.

Home healthcare
US$12.30mSeries A · Nov 2025
80LinkedIn · Jul 2026
Fee-for-service
4 yr2022
0none in 3 months

Provider of contract based drug discovery services

Biopharma outsourcing
US$12.25mSeries B · Jan 2024
34recorded
Subscription
6 yr2020
—No postings tracked

Health system

Hospital chains
US$11.50mSeries B · Dec 2020
36-23% vs previous recordLinkedIn · Oct 2026
Subscription
10 yr2016
0none in 3 months

Company that provides integrated point-of-care testing solutions and AI-powered technology

Services for healthcare providers
US$11.40mAngel · Jan 2026
30LinkedIn · Jul 2026
Fee-for-service
5 yr2021
0none in 3 months
50 of 369 companies shown here · the full list is on Radar
Fliar Radar

Explore all 369 healthcare companies in Boston on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open healthcare in Boston on Radar
  • Every company, not just 50All 369 healthcare companies in Boston, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore healthcare companies in Boston by what you are looking for

Explore healthcare companies in Boston by care, research, and pharmaceutical focus. Compare healthcare startups in Boston with providers, biopharma partners, and hospital organizations.

7 ways to explore healthcare in Boston

Biopharma research & outsourcing companiesHealthcare provider servicesPharmaceutical companiesHospitals, clinics & home healthcareHealthcare startups in BostonHealthcare companies hiring in Boston

Biopharma research & outsourcing companies

Drug discovery, clinical development, and outsourced biopharma service providers.

  1. Superluminal Medicines

    Generative biological and chemical company focused on drug discovery

    Biopharma outsourcing
    See in list
  2. Manifold Bio

    Developer of tissue-targeted therapeutics using in vivo screening and AI design

    Medical research labs
    See in list
  3. GALY

    Provider of medical research labs

    Medical research labs
    See in list
  4. Peplib

    Provider of peptide drug discovery and development services for global pharmaceutical industries

    Biopharma outsourcing
    See in list
  5. Meadowhawk Biolabs

    CRO focused on providing of drug discovery, pharmacology, and bioanalytical services

    Biopharma outsourcing
    See in list

Healthcare provider services

Healthcare services, revenue management, and support for care providers.

  1. Nexcure

    Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers

    Services for healthcare providers
    See in list
  2. FamilyWell Health

    Provider of integrated perinatal mental health services for OB clinics. These services are delivered through a collaborative care model, integrating behavioral health support into existing obstetric practices. The model includes access to psychiatrists for medication management and billing support to facilitate insurance reimbursement. Services are offered both in-person and virtually, providing convenient access to mental health support for pregnant and postpartum patients. A certification program for perinatal behavioral health coaches is also offered.

    Home healthcare
    See in list
  3. Carna Health

    Company that provides integrated point-of-care testing solutions and AI-powered technology

    Services for healthcare providers
    See in list
  4. Pepper

    Provider of services for drug discovery and development services

    Services for healthcare providers
    See in list
  5. N1 Health

    AI platform for personalized healthcare, driving better health outcomes and results

    Services for healthcare providers
    See in list

Pharmaceutical companies

Pharmaceutical developers and companies working across therapies and medicines.

  1. Jnana Therapeutics

    Company developing a drug discovery platform for targeting the solute carrier (SLC) family of transporters

    Diversified pharmaceuticals
    See in list
  2. Pieris Pharmaceuticals

    Therapeutics based on recombinant engineered lipocalin mimics

    Diversified pharmaceuticals
    See in list
  3. Imbria Pharmaceuticals

    Provider of therapeutics solution by translation the cellular metabolism

    Diversified pharmaceuticals
    See in list
  4. NextRNA

    Developer of RNA-targeted therapeutics for multiple areas

    Diversified pharmaceuticals
    See in list
  5. Animol Discovery

    R&D company focused on manufacturing drugs for multiple therapeutic areas

    Diversified pharmaceuticals
    See in list

Hospitals, clinics & home healthcare

Hospitals, clinic networks, rehabilitation providers, and home healthcare services.

  1. Lusaris Therapeutics

    Provider of neuropsychiatric treatment services

    Rehabilitation and long-term care
    See in list
  2. InStride Health

    Provider of anxiety management & therapy services

    Rehabilitation and long-term care
    See in list
  3. Nexcure

    Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers

    Services for healthcare providers
    See in list
  4. Engooden

    Health system

    Hospital chains
    See in list
  5. Edenbridge Health

    Provider of elderly care services

    Home healthcare
    See in list

Healthcare startups in Boston

Newer healthcare companies in Boston building care and life science services.

  1. Superluminal Medicines

    Generative biological and chemical company focused on drug discovery

    Biopharma outsourcing
    See in list
  2. Lusaris Therapeutics

    Provider of neuropsychiatric treatment services

    Rehabilitation and long-term care
    See in list
  3. InStride Health

    Provider of anxiety management & therapy services

    Rehabilitation and long-term care
    See in list
  4. Meadowhawk Biolabs

    CRO focused on providing of drug discovery, pharmacology, and bioanalytical services

    Biopharma outsourcing
    See in list
  5. Nexcure

    Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers

    Services for healthcare providers
    See in list
62 companies in Boston

Healthcare companies hiring in Boston

Healthcare employers in Boston with active hiring signals.

  1. Ventus Therapeutics

    Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment

    Biopharma outsourcing
    See in list
  2. Jnana Therapeutics

    Company developing a drug discovery platform for targeting the solute carrier (SLC) family of transporters

    Diversified pharmaceuticals
    See in list
  3. Superluminal Medicines

    Generative biological and chemical company focused on drug discovery

    Biopharma outsourcing
    See in list
  4. Mercy BioAnalytics

    Manufacturer of diagnostic test devices

    Traditional diagnostics
    See in list
  5. Manifold Bio

    Developer of tissue-targeted therapeutics using in vivo screening and AI design

    Medical research labs
    See in list
22 companies in Boston

Public healthcare companies in Boston

Publicly listed healthcare companies based in Boston.

  1. Pieris Pharmaceuticals

    Therapeutics based on recombinant engineered lipocalin mimics

    Diversified pharmaceuticals
    See in list
  2. Restorbio

    Reviews beauty products, ingredients, and promotes informed skincare, hair, and body choices

    Diversified pharmaceuticals
    See in list
  3. Vertex Pharmaceuticals

    Developer of drugs for the treatment of multiple disorders

    Diversified pharmaceuticals
    Website
  4. SAGE Therapeutics

    Developer of drug candidates for the treatment of rare CNS disorders

    Neurology
    Website
  5. Locust Walk

    Provider of market analytics services to biopharma sector

    Biopharma outsourcing
    Website
9 companies in Boston
Mobile reach

Top 10 healthcare apps from Boston

The most-installed Android apps published by healthcare companies headquartered in Boston — 1.6M installs between them. 14 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 10
5

Wally Health

by Wally

Installs2K
Rating2.176 ratings
Last updatedDec 2025
View on Google Play ↗
Wally Health screenshot 1Wally Health screenshot 2
RadarBrowse every healthcare company in Boston on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Healthcare funding and M&A across the United States

5,744 recorded equity rounds have gone to 69,903 healthcare companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Boston compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months120

US$1.59bn

equity rounds, last 24 months419

US$10.04bn

raised over five yearsUS$40.20bn

2,242 rounds in the United States

M&A deals, Boston52

last 24 months

Capital by year

Equity funding into healthcare in the United States

amount rounds
$6.9bn2018333
$4.2bn2019385
$5.1bn2020380
$10bn2021460
$8.9bn2022509
$6.6bn2023507
$4.7bn2024379
$8.3bn2025292
$1.3bn202695

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$10.33bn across 460 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$18.67m10 rounds · median US$4.00m
SeedUS$1.86bn959 rounds · median US$799k
Series AUS$9.38bn626 rounds · median US$7.91m
Series BUS$13.02bn340 rounds · median US$20.00m
Series CUS$7.17bn120 rounds · median US$47.88m
Series D+US$6.09bn58 rounds · median US$75.00m
Private equityUS$2.66bn129 rounds · median US$115.00m
Where the money went · five years

Most-funded sub-sectors

Biopharma outsourcingUS$8.79bn312 rounds · 211 companies
Services for healthcare providersUS$8.13bn346 rounds · 211 companies
Clinic chainsUS$3.49bn159 rounds · 98 companies
Diversified pharmaceuticalsUS$2.53bn96 rounds · 54 companies
Rehabilitation and long-term careUS$1.89bn153 rounds · 102 companies
Traditional pharmaceuticalsUS$1.84bn46 rounds · 36 companies
Home healthcareUS$1.58bn140 rounds · 99 companies
Corporate activity · last 24 months

M&A in Boston

49Acquisition
3Merger

Most active acquirers

  1. Genzyme29
  2. Eli lilly2
  3. Supernus pharmaceuticals2
  4. Sevita2
  5. Vertex pharmaceuticals2

Most acquired or merged

  1. Sage therapeutics3
  2. Centessa pharmaceuticals2
  3. Steward health care1
  4. Hayden consulting group1
  5. Na1

Each deal appears in the events strip at the top of the page.

Industry landscape report

AdTech Industry Landscape of Boston

The financials above are one chapter. The full healthcare landscape of Boston maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the healthcare landscape of Boston

Healthcare funding in Boston

51 healthcare companies in Boston have recorded equity funding, US$1.81bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Boston

Meet the people behind healthcare companies in Boston. 139 of 369 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Boston healthcare companies by sub-sector

The most common specialisations among healthcare companies in Boston. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring healthcare in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in Boston

134 more company lists you can search, plus the Radar directory pages for each place.

Healthcare in nearby cities

Healthcare in other US cities

Other sectors in Boston

Browse the Radar directory

Coming soon